Clinical Trials
34 trialsPeople's Hospital of Xinjiang Uygur Autonomous Region
People's Hospital of Xinjiang Uygur Autonomous Region
MYELAXAT
University Hospital, Grenoble
CARAVAGGIO
Fadoi Foundation, Italy
Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer
LEO Pharma
AIRPORT-MPN
Ottawa Hospital Research Institute
ROSIE
Radboud University Medical Center
CANVAS
Alliance Foundation Trials, LLC.
APEX
Alexion Pharmaceuticals, Inc.
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
Duke University
Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery
McMaster University
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy
University of Colorado, Denver
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
Dana-Farber Cancer Institute
A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants
Janssen Research & Development, LLC
Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
Huazhong University of Science and Technology
Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis
Case Comprehensive Cancer Center
Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients
Pfizer
Cancer Venous Thromboembolism (VTE)
Daiichi Sankyo
AVERT
Ottawa Hospital Research Institute
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
McMaster University
CASTA-DIVA
Assistance Publique - Hôpitaux de Paris
DISOLVE
University of Vermont
ACT
Thomas Jefferson University
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Altor BioScience
SOME
Ottawa Hospital Research Institute
The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery
Shanghai Zhongshan Hospital
Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer
University of Alabama at Birmingham
SAVE-ONCO
Sanofi
Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients
Duke University
CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)
Rovi Pharmaceuticals Laboratories
Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery
Sanofi
Screening for Occult Malignancy in Idiopathic Venous Thromboembolism
University of Padova
Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients
Ontario Clinical Oncology Group (OCOG)